Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of Exforge and Lipitor in Healthy Volunteers
NCT02069821Phase 1Completed
- Sponsor
- HK inno.N Corporation
- Start
- Mar 2014
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of amlodipine + valsartan + atorvastatin in hypertension (HTN) and hyperlipidemia (2 arms), sponsored by HK inno.N Corporation. Primary endpoints: Pharmacokinetic interaction of amlodipine, Pharmacokinetic interaction of valsartan and 2 more. Started Mar 2014; status: completed.
02
Drugs
amlodipine + valsartan + atorvastatin
03
Conditions
hypertension (HTN)hyperlipidemia
Beyond the preview
Go deeper on NCT02069821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02069821.